Literature DB >> 9922346

Angiographic frame counts 90 minutes after streptokinase predict left ventricular function at 48 hours following myocardial infarction.

J K French1, I T Straznicky, B J Webber, P E Aylward, M J Frey, A A Adgey, B F Williams, S C McLaughlin, H D White.   

Abstract

OBJECTIVE: To assess whether the 90 minute corrected thrombolysis in myocardial infarction frame count (CTFC) in the infarct related artery predicts left ventricular function at 48 hours in patients with myocardial infarction treated with aspirin, streptokinase, and either heparin or Hirulog. DESIGN AND
SETTING: Analysis of 251 patients with acute myocardial infarction enrolled in the international, multicentre Hirulog early reperfusion/occlusion (HERO-1) trial, who underwent both 90 minute coronary angiography and 48 hour left ventriculography. MAIN OUTCOME VARIABLES: The CTFC was determined in the infarct related artery 90 minutes after starting intravenous streptokinase (1.5 x 106 U over 30 to 60 minutes), and compared with indices of left ventricular function assessed by contrast ventriculography at 48 hours.
RESULTS: A CTFC of </= 27 frames (previously reported mean + 2 SD in coronary arteries of patients without acute infarction) occurred in 29% of infarct related arteries, and was associated with a lower infarct zone mean chord score (-2.06 v -2.54, p = 0.01), a lower fraction of chords > 2 SD below normal (37% v 51%, p = 0.005), and trends towards higher left ventricular ejection fractions (60.9% v 58.2%, p = 0.11) and lower end systolic volumes (50.1 ml v 55.9 ml, p = 0.23). A CTFC of </= 40 at 90 minutes occurred in 50% of infarct related arteries, and was associated with a significantly lower mean chord score (-2.20 v -2.60, p = 0.02), a smaller fraction of chords > 2 SD below normal (41% v 52%, p = 0.025), a smaller end systolic volume (49.1 ml v 59.3 ml, p = 0.02), and a higher left ventricular ejection fraction (60.4% v 56.5%, p = 0.03).
CONCLUSIONS: The 90 minute CTFC predicts left ventricular function at 48 hours following streptokinase. The CTFC associated with better ventricular function may be higher than values determined from a non-infarct population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9922346      PMCID: PMC1728934     

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  14 in total

1.  Simplicity's virtue scorned. Precision comes to TIMI flow grading and the results are ...surprising.

Authors:  C W White
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

2.  Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators.

Authors:  H D White; P E Aylward; M J Frey; A A Adgey; R Nair; W S Hillis; Y Shalev; M A Brown; J K French; R Collins; J Maraganore; B Adelman
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

3.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Authors:  J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

4.  Comparison of the effects of streptokinase and tissue plasminogen activator on regional wall motion after first myocardial infarction: analysis by the centerline method with correction for area at risk.

Authors:  D B Cross; N G Ashton; R M Norris; H D White
Journal:  J Am Coll Cardiol       Date:  1991-04       Impact factor: 24.094

5.  Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.

Authors:  R J Simes; E J Topol; D R Holmes; H D White; W R Rutsch; A Vahanian; M L Simoons; D Morris; A Betriu; R M Califf
Journal:  Circulation       Date:  1995-04-01       Impact factor: 29.690

6.  Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies.

Authors:  A Vogt; R von Essen; U Tebbe; W Feuerer; K F Appel; K L Neuhaus
Journal:  J Am Coll Cardiol       Date:  1993-05       Impact factor: 24.094

7.  TIMI frame count: a quantitative method of assessing coronary artery flow.

Authors:  C M Gibson; C P Cannon; W L Daley; J T Dodge; B Alexander; S J Marble; C H McCabe; L Raymond; T Fortin; W K Poole; E Braunwald
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

8.  Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction.

Authors:  N G Uren; T Crake; D C Lefroy; R de Silva; G J Davies; A Maseri
Journal:  N Engl J Med       Date:  1994-07-28       Impact factor: 91.245

Review 9.  The stunned myocardium: prolonged, postischemic ventricular dysfunction.

Authors:  E Braunwald; R A Kloner
Journal:  Circulation       Date:  1982-12       Impact factor: 29.690

10.  TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study.

Authors:  J L Anderson; L A Karagounis; L C Becker; S G Sorensen; R L Menlove
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

View more
  1 in total

1.  Importance of the TIMI frame count: implications for future trials.

Authors:  Mark A Appleby; Andrew D Michaels; Michael Chen; C Gibson Michael
Journal:  Curr Control Trials Cardiovasc Med       Date:  2000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.